- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06457412
Programme for Intervention in Paediatric Obesity (PinPo)
June 7, 2024 updated by: Maimónides Biomedical Research Institute of Córdoba
The PinPo program aims to carry out a comprehensive intervention for children aged 6 to 12 years with childhood obesity (with a BMI greater than the 99th percentile), fostering motivation and encouraging changes toward healthy lifestyle habits to achieve greater adherence and improved health.
The program comprises 9 educational sessions designed by specialized professionals from various disciplines (pediatrics, psychology, nursing, nutrition), for a group of 10 children and another group of 10 family members and/or caregivers.
These sessions are conducted in a hospital setting every 15 days, each lasting 90 minutes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mercedes Gil-Campos, MD, Phd
- Phone Number: +34957736467
- Email: mercedes_gil_campos@yahoo.es
Study Locations
-
-
-
Córdoba, Spain
- Recruiting
- Hospital Universitario Reina Sofia
-
Contact:
- Mercedes Gil-Campos, PhD, MD
- Email: mercedes_gil_campos@yahoo.es
-
Principal Investigator:
- Mercedes Gil-Campos
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Children between 6 and 12 years old, with a BMI greater than the 99th percentile according to Cole criteria (2004).
Exclusion Criteria:
- Children < 6, or > 12 years.
- Children with chronic diseases or following a therapeutic diet.
- Children with intervention in other centers.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
Intervention group for the treatment of childhood obesity
|
Intervention for children aged 6 to 12 years with childhood obesity (with a BMI greater than the 99th percentile), fostering motivation and encouraging changes toward healthy lifestyle habits to achieve greater adherence and to improve health.
The program comprises 9 educational sessions designed by specialized professionals (code of Spanish register: 2007144741729) to be conducted in a health center.
The sessions will be held every 15 days, with a duration of 90 minutes for a group of 10 children and another group of 10 family members and/or caregivers.
Professionals from different disciplines (paediatricians, psychologists, nurses and nutritionists), will meet with groups of pediatric patients and in another group with their family members or primary caregivers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary intake
Time Frame: 4 months
|
The daily energy intake will be estimated using data from three internationally validated questionnaires: the adapted Consumption Frequency Questionnaire (CFC), the NHANES Food Questionnaire, and the Kidmed Test.
The unit of measurement is kilocalories.
|
4 months
|
|
Diet composition
Time Frame: 4 months
|
The composition of the diet by macronutrients and micronutrients will be estimated using data from three internationally validated questionnaires: the adapted Consumption Frequency Questionnaire (CFC), the NHANES Food Questionnaire, and the Kidmed Test.
The unit of measurement is grams.
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical activity and sedentary behavior
Time Frame: 4 months
|
Physical activity and sedentary behavior will be assessed in terms of time using an ad hoc questionnaire.
The unit of measurement is minutes.
|
4 months
|
|
Screen Time
Time Frame: 4 months
|
Screen time (including television, computers, cell phones, video games, and consoles) will be assessed in terms of time using an ad hoc questionnaire.
The unit of measurement is minutes of screen display.
|
4 months
|
|
Height
Time Frame: 4 months
|
Height in centimeters is measured with the SECA 213 precision measuring instrument.
|
4 months
|
|
Weight
Time Frame: 4 months
|
Weight in grams is measured by the precision weighing scale model Tanita 780PMA
|
4 months
|
|
Body mass index
Time Frame: 4 months
|
Body mass index in kilograms per square meter is calculated.
|
4 months
|
|
Waist circumference
Time Frame: 4 months
|
Waist circumference in centimeters is measured with a CESCORF measuring tape
|
4 months
|
|
Self-esteem
Time Frame: 4 months
|
Self-esteem will be evaluated using ad hoc questionnaires.
It will be measured by obtaining a score.
|
4 months
|
|
Confidence
Time Frame: 4 months
|
Confidence will be evaluated using ad hoc questionnaires.
It will be measured by obtaining a score.
|
4 months
|
|
Emotional Regulation
Time Frame: 4 months
|
Emotional regulation will be evaluated using ad hoc questionnaires.
It will be measured by obtaining a score.
|
4 months
|
|
Hematological analysis: Hemoglobine
Time Frame: 4 months
|
Hemoglobin levels are determined in grams per deciliter on an individual basis.
|
4 months
|
|
Hematological analysis: Hematocrite
Time Frame: 4 months
|
Hematocrite levels are determined in percentage on an individual basis.
|
4 months
|
|
Hematological analysis: Erythrocytes
Time Frame: 4 months
|
Erythrocytes count is measured in 10e06 units per microliter on an individual basis.
|
4 months
|
|
Hematological analysis: Mean corpuscular volume
Time Frame: 4 months
|
Mean corpuscular volume is measured in femtoliters on an individual basis.
|
4 months
|
|
Hematological analysis: Mean corpuscular hemoglobin
Time Frame: 4 months
|
Mean corpuscular hemoglobine is measured in picograms on an individual basis.
|
4 months
|
|
Hematological analysis: Mean corpuscular hemoglobin concentration
Time Frame: 4 months
|
Mean corpuscular hemoglobine concentration is measured in grams per deciliter on an individual basis.
|
4 months
|
|
Hematological analysis: Red cell blood distribution width
Time Frame: 4 months
|
Red cell blood distribution width is determined in percentage on an individual basis.
|
4 months
|
|
Hematological analysis: White blood cells
Time Frame: 4 months
|
White blood cells count is measured in 10e03 units per microliter on an individual basis.
|
4 months
|
|
Hematological analysis: Neutrophils
Time Frame: 4 months
|
Neutrophils count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
4 months
|
|
Hematological analysis: Lymphocytes
Time Frame: 4 months
|
Lymphocytes count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
4 months
|
|
Hematological analysis: Monocytes
Time Frame: 4 months
|
Monocytes count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
4 months
|
|
Hematological analysis: Eosinophils
Time Frame: 4 months
|
Eosinophils count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
4 months
|
|
Hematological analysis: Basophiles
Time Frame: 4 months
|
Basophiles count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
4 months
|
|
Hematological analysis: Platelets
Time Frame: 4 months
|
Platelets count is measured in 10e03 units per microliter on an individual basis.
|
4 months
|
|
Hematological analysis: Mean platelet volume
Time Frame: 4 months
|
Mean platelet volume is measured in femtoliters on an individual basis.
|
4 months
|
|
Biochemical analysis: Glucose
Time Frame: 4 months
|
Glucose is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Bilirubin
Time Frame: 4 months
|
Total bilirubin is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma
|
4 months
|
|
Biochemical analysis: Creatinine
Time Frame: 4 months
|
Creatinine is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Urate
Time Frame: 4 months
|
Urate is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Urea
Time Frame: 4 months
|
Urea is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Total protein
Time Frame: 4 months
|
Total protein is measured both in grams per deciliter and in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Aspartate aminotransferase
Time Frame: 4 months
|
Aspartate aminotransferase is measured in international units per liter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Alanine aminotransferase
Time Frame: 4 months
|
Alanine aminotransferase is measured in international units per liter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Gamma-glutamyl transferase
Time Frame: 4 months
|
Gamma-glutamyl transferase is measured in international units per liter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Alkaline phosphatase
Time Frame: 4 months
|
Alkaline phosphatase is measured in international units per liter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Total cholesterol
Time Frame: 4 months
|
Total cholesterol is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: High density lipoproteins
Time Frame: 4 months
|
High density lipoproteins (HDL) are measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Non-HDL cholesterol
Time Frame: 4 months
|
Non-HDL cholesterol levels are calculated in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Low density lipoproteins
Time Frame: 4 months
|
Low density lipoproteins (LDL) are measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Apolipoprotein A1
Time Frame: 4 months
|
Apolipoprotein A1 is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Apolipoprotein B
Time Frame: 4 months
|
Apolipoprotein B is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Calcium
Time Frame: 4 months
|
Calcium is measured both in milligrams per deciliter and in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Potassium
Time Frame: 4 months
|
Potassium is measured both in millimoles per liter and in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Sodium
Time Frame: 4 months
|
Sodium is measured in millimoles per liter, in milliequivalents per liter and in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Phosphorus
Time Frame: 4 months
|
Phosphorus is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Iron
Time Frame: 4 months
|
Iron is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Magnesium
Time Frame: 4 months
|
Magnesium is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Zinc
Time Frame: 4 months
|
Zinc is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Insulin
Time Frame: 4 months
|
Insulin is measured both in micro international units per liter and in picograms per milliliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Insulin resistance
Time Frame: 4 months
|
The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index is used to estimate insulin resistance.
|
4 months
|
|
Biochemical analysis: C-reactive protein
Time Frame: 4 months
|
C-reactive protein is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Tumor necrosis factor alpha
Time Frame: 4 months
|
Tumor necrosis factor alpha is measured in picograms per deciliter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Adiponectin
Time Frame: 4 months
|
Adiponectin is measured in milligrams per liter on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Energy
Time Frame: 4 months
|
Adiponectin is measured in milligrams per liter on an individual basis.
Analysis performed Energy is determined in kilocalories on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Carbohydrates
Time Frame: 4 months
|
Adiponectin is measured in milligrams per liter on an individual basis.
Analysis performed Carbohydrates are measured in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Sugars
Time Frame: 4 months
|
Sugars are measured in grams on an individual basis.
Analysis performed in plasma.Carbohydrates are measured in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Fiber
Time Frame: 4 months
|
Fibers are measured in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Polysaccharides
Time Frame: 4 months
|
Polysaccharides are measured in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Total fat
Time Frame: 4 months
|
Total fat is measured in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Saturated fatty acids
Time Frame: 4 months
|
Saturated fatty acids are measured in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Monounsaturated fatty acids
Time Frame: 4 months
|
Monounsaturated fatty acids are measured in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Polyunsaturated fatty acids
Time Frame: 4 months
|
Polyunsaturated fatty acids are measured in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Vitamin B1
Time Frame: 4 months
|
Vitamin B1 is measured in milligrams on an individual basis.
Analysis performed in plasma
|
4 months
|
|
Biochemical analysis: Vitamin B2
Time Frame: 4 months
|
Vitamin B2 is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Vitamin B3
Time Frame: 4 months
|
Vitamin B3 is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Vitamin B6
Time Frame: 4 months
|
Vitamin B6 is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Vitamin B9
Time Frame: 4 months
|
Vitamin B9 is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Vitamin B12
Time Frame: 4 months
|
Vitamin B12 is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Vitamin C
Time Frame: 4 months
|
Vitamin C is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Vitamin A
Time Frame: 4 months
|
Vitamin A is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Vitamin D
Time Frame: 4 months
|
Vitamin D is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Vitamin E
Time Frame: 4 months
|
Vitamin E is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Carotenes
Time Frame: 4 months
|
Carotenes are measured in micrograms on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Retinol
Time Frame: 4 months
|
Retinol is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Biochemical analysis: Water
Time Frame: 4 months
|
Water is measured in grams on an individual basis.
Analysis performed in plasma.
|
4 months
|
|
Fecal microbiome: DNA
Time Frame: 4 months
|
Samples will be homogenized in a Stomacher-400 blender.
Subsequently, a QIAamp DNA Stool Mini Kit (QIAGEN, Barcelona, Spain) will be used for the DNA extraction as indicated by the manufacturer with the exception of the incubation at 70 °C, since the samples will be mixed with the lysis buffer and incubated at a temperature of 95 °C to ensure that both Gram-positive and Gram-negative bacteria are lysed.
The quantification of the DNA will be conducted with a NanoDrop ND1000 spectrophotometer (Thermo Fisher Scientific, DE, USA) and the DNA yield will be calculated by measuring absorbance ratios spectrophotometrically, including A260/230 nm for salt and phenol contamination and A260/280 nm for protein contamination.
The unit of measurement is percentage of abundance.
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2022
Primary Completion (Estimated)
March 1, 2032
Study Completion (Estimated)
March 1, 2032
Study Registration Dates
First Submitted
May 27, 2024
First Submitted That Met QC Criteria
June 7, 2024
First Posted (Actual)
June 13, 2024
Study Record Updates
Last Update Posted (Actual)
June 13, 2024
Last Update Submitted That Met QC Criteria
June 7, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PinPo
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity, Childhood
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Universidad de SonoraCentro de Investigación en Alimentación y Desarrollo A.C.; Instituto Nacional...Not yet recruitingChildhood Obesity Pevention
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaCompletedPrevention Childhood ObesityMexico
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
Clinical Trials on Intervention group for the treatment of childhood obesity
-
Universiti Putra MalaysiaCompletedChildhood Obesity | Life Style Modification
-
University of MinnesotaCompleted
-
University of California, San DiegoCompleted
-
Holbaek SygehusUniversity of Copenhagen; Herlev Hospital; The Novo Nordisk Foundation Center... and other collaboratorsCompletedHypertension | Childhood Obesity | Hyperlipidemia | Insulin Sensitivity | NAFLD (Non-alcoholic Fatty Liver Disease)Denmark
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaActive, not recruitingPrevention and Control | Obesity/therapyMexico
-
ALI BAHADIRLIBursa Yüksek İhtisas Education and Research HospitalCompletedGestational Diabetes Mellitus in PregnancyTurkey
-
RANI TherapeuticsRecruiting
-
Technical University of LisbonUnknown
-
University of AarhusRanders Municipality, Denmark; Aarhus KommuneCompleted
-
University of AarhusResearch Unit for General Practice, Aarhus UniversityCompletedPrecursor Cell Lymphoblastic Leukemia-LymphomaDenmark